_id
6919e97c3c536f8df23182be
Ticker
IBT.LSE
Name
International Biotechnology Trust plc
Exchange
LSE
Address
31 Gresham Street, London, United Kingdom, EC2V 7QA
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.internationalbiotrust.com
Description
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of the
Last Close
9720000
Volume
6099
Current Price
978.0677
Change
-1.2345679012345678
Last Updated
2025-12-30T11:04:09.275Z
Image
https://logo.clearbit.com/www.internationalbiotrust.com
Ipo Date
-
Market Cap
310095552
Next Dividend Date
2026-01-23T00:00:00.000Z
Dividend Frequency
Interim
Dividend Rate
0.1564
Dividend Yield
0.06396285246921048
Sentiment
-
Sentiment Sources
0
Rating
3.5
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-08-31
Revenue
5991000
Cost Of Revenue
1533000
Gross Profit
1688000
Operating Expenses
-
Operating Income
-9447000
Interest Expense
-
Pretax Income
-8194000
Net Income
-8204000
Eps
-0.2308297431720863
Dividends Per Share
5570000
Shares Outstanding
31902834
Income Tax Expense
10000
EBITDA
-9447000
Operating Margin
-157.68652979469204
Total Other Income Expense Net
1252999
Cash
14980000
Short Term Investments
-
Receivables
66000
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
284036000
Payables
2063000
Short Term Debt
29607000
Long Term Debt
-
Total Liabilities
34627000
Equity
249409000
Bs_currency_symbol
GBP
Depreciation
-
Change In Working Capital
566000
Cash From Operations
31304000
Capital Expenditures
31304000
Cash From Investing
-
Cash From Financing
-20532000
Net Change In Cash
10733000
Cf_currency_symbol
-
PE
-
PB
139.3768609600772
ROE
-3.289376085065094
ROA
-2.888366263431396
FCF
0
Fcf Percent
-
Piotroski FScore
2
Health Score
26
Deep Value Investing Score
3.5
Defensive Investing Score
6.5
Dividend Investing Score
2
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
1.5
Momentum Investing Score
7.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
3.5
Quarters > 0 > quarter
2025-08-31
Quarters > 0 > income Statement > revenue
5991000
Quarters > 0 > income Statement > cost Of Revenue
1533000
Quarters > 0 > income Statement > gross Profit
1688000
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-9447000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-8194000
Quarters > 0 > income Statement > net Income
-8204000
Quarters > 0 > income Statement > eps
-0.2308297431720863
Quarters > 0 > income Statement > dividends Per Share
5570000
Quarters > 0 > income Statement > shares Outstanding
35541347
Quarters > 0 > income Statement > income Tax Expense
10000
Quarters > 0 > income Statement > EBITDA
-9447000
Quarters > 0 > income Statement > operating Margin
-157.68652979469204
Quarters > 0 > income Statement > total Other Income Expense Net
1252999
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
14980000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
66000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
284036000
Quarters > 0 > balance Sheet > payables
2063000
Quarters > 0 > balance Sheet > short Term Debt
29607000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
34627000
Quarters > 0 > balance Sheet > equity
249409000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-8204000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
566000
Quarters > 0 > cash Flow > cash From Operations
31304000
Quarters > 0 > cash Flow > capital Expenditures
31304000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-20532000
Quarters > 0 > cash Flow > net Change In Cash
10733000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.2308297431720863
Quarters > 0 > ratios > PB
139.3768609600772
Quarters > 0 > ratios > ROE
-3.289376085065094
Quarters > 0 > ratios > ROA
-2.888366263431396
Quarters > 0 > ratios > FCF
0
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
26
Quarters > 1 > quarter
2025-02-28
Quarters > 1 > income Statement > revenue
12695000
Quarters > 1 > income Statement > cost Of Revenue
2770000
Quarters > 1 > income Statement > gross Profit
12695000
Quarters > 1 > income Statement > operating Expenses
3269000
Quarters > 1 > income Statement > operating Income
9426000
Quarters > 1 > income Statement > interest Expense
917000
Quarters > 1 > income Statement > pretax Income
7052000
Quarters > 1 > income Statement > net Income
7034000
Quarters > 1 > income Statement > eps
0.19407696097883215
Quarters > 1 > income Statement > dividends Per Share
5626000
Quarters > 1 > income Statement > shares Outstanding
36243354
Quarters > 1 > income Statement > income Tax Expense
18000
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
74.24970460811343
Quarters > 1 > income Statement > total Other Income Expense Net
-2374000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
4247000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
906000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
5153000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
316198000
Quarters > 1 > balance Sheet > payables
5876000
Quarters > 1 > balance Sheet > short Term Debt
35738000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
41614000
Quarters > 1 > balance Sheet > equity
274584000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
7034000
Quarters > 1 > cash Flow > depreciation
-9426000
Quarters > 1 > cash Flow > change In Working Capital
20000
Quarters > 1 > cash Flow > cash From Operations
-2671000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-254000
Quarters > 1 > cash Flow > cash From Financing
-3393000
Quarters > 1 > cash Flow > net Change In Cash
-6186000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.19407696097883215
Quarters > 1 > ratios > PB
129.09875989520802
Quarters > 1 > ratios > ROE
2.561693325175538
Quarters > 1 > ratios > ROA
2.2245555000347883
Quarters > 1 > ratios > FCF
-2671000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.21039779440724696
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2024-08-31
Quarters > 2 > income Statement > revenue
10469000
Quarters > 2 > income Statement > cost Of Revenue
-457000
Quarters > 2 > income Statement > gross Profit
10926000
Quarters > 2 > income Statement > operating Expenses
49000
Quarters > 2 > income Statement > operating Income
10518000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
10607000
Quarters > 2 > income Statement > net Income
10543000
Quarters > 2 > income Statement > eps
0.2862230422172879
Quarters > 2 > income Statement > dividends Per Share
5377000
Quarters > 2 > income Statement > shares Outstanding
36834910
Quarters > 2 > income Statement > income Tax Expense
64000
Quarters > 2 > income Statement > EBITDA
10518000
Quarters > 2 > income Statement > operating Margin
100.46804852421434
Quarters > 2 > income Statement > total Other Income Expense Net
89000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
10433000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
109000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
10648000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
308155000
Quarters > 2 > balance Sheet > payables
1872000
Quarters > 2 > balance Sheet > short Term Debt
22827000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
25890000
Quarters > 2 > balance Sheet > equity
282265000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
10543000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-1736000
Quarters > 2 > cash Flow > cash From Operations
-33819000
Quarters > 2 > cash Flow > capital Expenditures
16643999
Quarters > 2 > cash Flow > cash From Investing
53627000
Quarters > 2 > cash Flow > cash From Financing
-18364000
Quarters > 2 > cash Flow > net Change In Cash
1206000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.2862230422172879
Quarters > 2 > ratios > PB
127.63550459110056
Quarters > 2 > ratios > ROE
3.7351425079269482
Quarters > 2 > ratios > ROA
3.4213301747497207
Quarters > 2 > ratios > FCF
-50462999
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-4.820231063138791
Quarters > 2 > health Score
47
Quarters > 3 > quarter
2024-02-29
Quarters > 3 > income Statement > revenue
32414000
Quarters > 3 > income Statement > cost Of Revenue
5316000
Quarters > 3 > income Statement > gross Profit
27098000
Quarters > 3 > income Statement > operating Expenses
3379000
Quarters > 3 > income Statement > operating Income
29035000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
28404000
Quarters > 3 > income Statement > net Income
28333000
Quarters > 3 > income Statement > eps
0.7287322915648304
Quarters > 3 > income Statement > dividends Per Share
5391000
Quarters > 3 > income Statement > shares Outstanding
38879847
Quarters > 3 > income Statement > income Tax Expense
71000
Quarters > 3 > income Statement > EBITDA
-631000
Quarters > 3 > income Statement > operating Margin
89.5754920713272
Quarters > 3 > income Statement > total Other Income Expense Net
-631000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
9227000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
6474000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
15701000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
320769000
Quarters > 3 > balance Sheet > payables
6591000
Quarters > 3 > balance Sheet > short Term Debt
27669000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
34260000
Quarters > 3 > balance Sheet > equity
286509000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
28333000
Quarters > 3 > cash Flow > depreciation
-29035000
Quarters > 3 > cash Flow > change In Working Capital
1004000
Quarters > 3 > cash Flow > cash From Operations
28708000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-3164000
Quarters > 3 > cash Flow > cash From Financing
16166000
Quarters > 3 > cash Flow > net Change In Cash
9227000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.7287322915648304
Quarters > 3 > ratios > PB
132.72575218105504
Quarters > 3 > ratios > ROE
9.889043625156626
Quarters > 3 > ratios > ROA
8.83283609076937
Quarters > 3 > ratios > FCF
28708000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.8856666872339113
Quarters > 3 > health Score
78
Annuals > 0 > quarter
2025-08-31
Annuals > 0 > income Statement > revenue
18686000
Annuals > 0 > income Statement > cost Of Revenue
4303000
Annuals > 0 > income Statement > gross Profit
14383000
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-21000
Annuals > 0 > income Statement > interest Expense
1940000
Annuals > 0 > income Statement > pretax Income
-1142000
Annuals > 0 > income Statement > net Income
-1170000
Annuals > 0 > income Statement > eps
-0.03291940510864712
Annuals > 0 > income Statement > dividends Per Share
11196000
Annuals > 0 > income Statement > shares Outstanding
35541347
Annuals > 0 > income Statement > income Tax Expense
28000
Annuals > 0 > income Statement > EBITDA
-21000
Annuals > 0 > income Statement > operating Margin
-0.11238360269720646
Annuals > 0 > income Statement > total Other Income Expense Net
-1121000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
14980000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
66000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
-
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
284036000
Annuals > 0 > balance Sheet > payables
2063000
Annuals > 0 > balance Sheet > short Term Debt
29607000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
34627000
Annuals > 0 > balance Sheet > equity
249409000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-1170000
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
1775000
Annuals > 0 > cash Flow > cash From Operations
28633000
Annuals > 0 > cash Flow > capital Expenditures
28633000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-23925000
Annuals > 0 > cash Flow > net Change In Cash
4547000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.03291940510864712
Annuals > 0 > ratios > PB
137.81225735961974
Annuals > 0 > ratios > ROE
-0.4691089736136226
Annuals > 0 > ratios > ROA
-0.4119196158233463
Annuals > 0 > ratios > FCF
0
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2024-08-31
Annuals > 1 > income Statement > revenue
42338000
Annuals > 1 > income Statement > cost Of Revenue
2198000
Annuals > 1 > income Statement > gross Profit
40140000
Annuals > 1 > income Statement > operating Expenses
1129000
Annuals > 1 > income Statement > operating Income
39553000
Annuals > 1 > income Statement > interest Expense
2198000
Annuals > 1 > income Statement > pretax Income
39011000
Annuals > 1 > income Statement > net Income
38876000
Annuals > 1 > income Statement > eps
1.018121974029457
Annuals > 1 > income Statement > dividends Per Share
10768000
Annuals > 1 > income Statement > shares Outstanding
38184030
Annuals > 1 > income Statement > income Tax Expense
135000
Annuals > 1 > income Statement > EBITDA
39553000
Annuals > 1 > income Statement > operating Margin
93.42198497803392
Annuals > 1 > income Statement > total Other Income Expense Net
-542000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
10433000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
109000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
10648000
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
308155000
Annuals > 1 > balance Sheet > payables
1872000
Annuals > 1 > balance Sheet > short Term Debt
22827000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
25890000
Annuals > 1 > balance Sheet > equity
282265000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
38876000
Annuals > 1 > cash Flow > depreciation
1656000
Annuals > 1 > cash Flow > change In Working Capital
-732000
Annuals > 1 > cash Flow > cash From Operations
45352000
Annuals > 1 > cash Flow > capital Expenditures
45352000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-2198000
Annuals > 1 > cash Flow > net Change In Cash
42907000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
1.018121974029457
Annuals > 1 > ratios > PB
130.82502202343898
Annuals > 1 > ratios > ROE
13.772873009406055
Annuals > 1 > ratios > ROA
12.61572909736983
Annuals > 1 > ratios > FCF
0
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
62
Annuals > 2 > quarter
2023-08-31
Annuals > 2 > income Statement > revenue
8494000
Annuals > 2 > income Statement > cost Of Revenue
2324000
Annuals > 2 > income Statement > gross Profit
8494000
Annuals > 2 > income Statement > operating Expenses
1559000
Annuals > 2 > income Statement > operating Income
6935000
Annuals > 2 > income Statement > interest Expense
1242000
Annuals > 2 > income Statement > pretax Income
6935000
Annuals > 2 > income Statement > net Income
6813000
Annuals > 2 > income Statement > eps
0.16787628102070554
Annuals > 2 > income Statement > dividends Per Share
11407000
Annuals > 2 > income Statement > shares Outstanding
40583458
Annuals > 2 > income Statement > income Tax Expense
122000
Annuals > 2 > income Statement > EBITDA
6935000
Annuals > 2 > income Statement > operating Margin
81.6458676712974
Annuals > 2 > income Statement > total Other Income Expense Net
349000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
0
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
2719000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
2719000
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
304871000
Annuals > 2 > balance Sheet > payables
143000
Annuals > 2 > balance Sheet > short Term Debt
32474000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
34554000
Annuals > 2 > balance Sheet > equity
270317000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
6935000
Annuals > 2 > cash Flow > depreciation
-6586000
Annuals > 2 > cash Flow > change In Working Capital
22063000
Annuals > 2 > cash Flow > cash From Operations
27299000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
21006000
Annuals > 2 > cash Flow > cash From Financing
-21385000
Annuals > 2 > cash Flow > net Change In Cash
7502000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
0.16787628102070554
Annuals > 2 > ratios > PB
145.1916947398632
Annuals > 2 > ratios > ROE
2.5203742272961005
Annuals > 2 > ratios > ROA
2.2347156666262125
Annuals > 2 > ratios > FCF
27299000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
3.2139157052036733
Annuals > 2 > health Score
64
Annuals > 3 > quarter
2022-08-31
Annuals > 3 > income Statement > revenue
-21104000
Annuals > 3 > income Statement > cost Of Revenue
2480000
Annuals > 3 > income Statement > gross Profit
-21104000
Annuals > 3 > income Statement > operating Expenses
1218000
Annuals > 3 > income Statement > operating Income
-21659000
Annuals > 3 > income Statement > interest Expense
663000
Annuals > 3 > income Statement > pretax Income
-22322000
Annuals > 3 > income Statement > net Income
-22473000
Annuals > 3 > income Statement > eps
-0.5471588981773641
Annuals > 3 > income Statement > dividends Per Share
12879000
Annuals > 3 > income Statement > shares Outstanding
41072164
Annuals > 3 > income Statement > income Tax Expense
151000
Annuals > 3 > income Statement > EBITDA
-21659000
Annuals > 3 > income Statement > operating Margin
102.62983320697498
Annuals > 3 > income Statement > total Other Income Expense Net
-663000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
0
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
13341000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
13409000
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
326916000
Annuals > 3 > balance Sheet > payables
1196000
Annuals > 3 > balance Sheet > short Term Debt
39976000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
42027000
Annuals > 3 > balance Sheet > equity
284889000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-22322000
Annuals > 3 > cash Flow > depreciation
17281000
Annuals > 3 > cash Flow > change In Working Capital
228000
Annuals > 3 > cash Flow > cash From Operations
1124000
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
19009000
Annuals > 3 > cash Flow > cash From Financing
-16413000
Annuals > 3 > cash Flow > net Change In Cash
-19664000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.5471588981773641
Annuals > 3 > ratios > PB
139.42414467692612
Annuals > 3 > ratios > ROE
-7.88833545696745
Annuals > 3 > ratios > ROA
-6.874242924788019
Annuals > 3 > ratios > FCF
1124000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-0.05326004548900682
Annuals > 3 > health Score
28
Valuation > metrics > PE
-0.2308297431720863
Valuation > metrics > PB
139.3768609600772
Valuation > final Score
20
Valuation > verdict
4545.9% Overvalued
Profitability > metrics > ROE
-3.289376085065094
Profitability > metrics > Net Margin
-1.3693874144550158
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.13883620879759753
Risk > metrics > Interest Coverage
-7.539505187549881
Risk > final Score
30
Risk > verdict
High
Liquidity > metrics > Current Ratio
0
Liquidity > metrics > Quick Ratio
0
Liquidity > final Score
10
Liquidity > verdict
Weak
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
65
Prev Profitabilities > 1
67
Prev Profitabilities > 2
80
Prev Risks > 0
100
Prev Risks > 1
100
Prev Risks > 2
64
Prev Liquidities > 0
16
Prev Liquidities > 1
32
Prev Liquidities > 2
33
Updated At
2026-01-20T23:02:01.939Z
Earnings History > 0 > period
2026-02-28
Earnings History > 0 > report Date
2026-05-11
Earnings History > 0 > date
2026-02-28
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-02-28
Earnings History > 1 > report Date
2025-05-13
Earnings History > 1 > date
2025-02-28
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.19
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0.19
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-08-31
Earnings History > 2 > report Date
2024-11-05
Earnings History > 2 > date
2024-08-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.28
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.28
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-02-28
Earnings History > 3 > report Date
2023-05-03
Earnings History > 3 > date
2023-02-28
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
0.42
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-08-31
Earnings History > 4 > report Date
2022-11-01
Earnings History > 4 > date
2022-08-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
0.64
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-02-28
Earnings History > 5 > report Date
2022-05-04
Earnings History > 5 > date
2022-02-28
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-1.18
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-1.18
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-08-31
Earnings History > 6 > report Date
2021-11-01
Earnings History > 6 > date
2021-08-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
0.21
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-02-28
Earnings History > 7 > report Date
2021-04-26
Earnings History > 7 > date
2021-02-28
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0.48
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-08-31
Earnings History > 8 > report Date
2020-11-02
Earnings History > 8 > date
2020-08-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
1.15
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
1.15
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-02-29
Earnings History > 9 > report Date
2020-04-27
Earnings History > 9 > date
2020-02-29
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
0.24
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.24
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-08-31
Earnings History > 10 > report Date
2019-10-30
Earnings History > 10 > date
2019-08-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
0.14
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0.14
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-02-28
Earnings History > 11 > report Date
2019-04-25
Earnings History > 11 > date
2019-02-28
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-0.61
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.61
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-08-31
Earnings History > 12 > report Date
2018-10-30
Earnings History > 12 > date
2018-08-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
1.09
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
1.09
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-02-28
Earnings History > 13 > report Date
2018-04-26
Earnings History > 13 > date
2018-02-28
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
-0.56
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.56
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-08-31
Earnings History > 14 > report Date
2017-11-03
Earnings History > 14 > date
2017-08-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
0.28
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0.28
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-02-28
Earnings History > 15 > report Date
2017-04-21
Earnings History > 15 > date
2017-02-28
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
0.93
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0.93
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-08-31
Earnings History > 16 > report Date
2016-11-04
Earnings History > 16 > date
2016-08-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
0.91
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0.91
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2016-02-29
Earnings History > 17 > report Date
2016-04-18
Earnings History > 17 > date
2016-02-29
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
-1.05
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-1.05
Earnings History > 17 > surprise Percent
-
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of the
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
0.1564Next Payout:
Jan 23, 2026Yield:
0.0640 %Main Market - London Stock Exchange
5/30/2020
Main Market London Stock Exchange
Read more →(Last Updated 2025-08-31)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-08-31)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of International Biotechnology Trust plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-02-28
EPS Estimate
—
Date
2025-02-28
EPS Actual
0.19
EPS Estimate
0
EPS Difference
0.19
Surprise Percent
0%
(Last Updated 2025-08-31)
(Last Updated 2025-08-31)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-08-31)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-08-31)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.